RENO, Nev., July 14, 2016 /PRNewswire/ -- When it comes to breast cancer detection technology, common sense dictates: The more tools medical professionals have in their toolkits to thoroughly investigate breast tissue, the better able they are to detect cancer early and increase the patient's chance of surviving.
In light of this, the team at SonoCiné is unveiling yet another groundbreaking tool with the release of 3D whole breast multiplanar reconstruction software. This new software package augments the already existing technology SonoCiné is known for: high-resolution transverse imaging.
"As a company, we are determined to virtually eliminate the underlying reasons for breast cancer mortality," said Elmar A. Davé, CEO of SonoCiné. "The SonoCiné Automated Whole Breast Ultrasound (AWBUS) has quickly become a leading detection technology. Now, with the addition of our 3D multiplanar reconstruction software, SonoCiné yet again has raised the standard of care in women's imaging."
What is SonoCiné AWBUS?
The SonoCiné AWBUS is an innovative medical imaging technology for early breast cancer detection. The FDA-cleared SonoCiné connects to standard ultrasound machines, and provides a consistent, repeatable scan of the whole breast, including the axilla (underarm / lymph nodes).
The new software package offers viewing in three dimensions. It maintains the high-resolution transverse view, and adds the coronal and sagittal views.
"Studies have shown that using the native transverse acquisition plane image is more reliable in detecting both benign and malignant masses," said Dr. A. Thomas Stavros, a board certified radiologist with 30 years experience in breast imaging and a breast ultrasound expert. "However, the coronal view is an added method to visualize the lesion once it has been detected, confirm its existence, distinguish it from artifact, and is particularly good for showing spiculation and architectural distortion in malignant masses."
How 3D Whole Breast Multiplanar Reconstruction Works
According to the team at SonoCiné, here's how the new software technology works: Once an area of suspicion has been identified using SonoCiné AWBUS, users of the new 3D software will be able to apply whole breast multiplanar reconstruction to further investigate the region. The 3D view shows the area being interrogated from all three planes — coronal, transverse and sagittal.
"This allows for a more thorough investigation of potential lesions, which can dramatically improve diagnostic abilities," Dr. Stavros said. "The fact that we're adding on to existing ultrasound systems is far more cost effective for health care providers, who don't have to invest in dedicated systems or purchase additional ultrasound units. This works with what they already have in their centers."
The Connection: Cancer and Dense Breast Tissue
The development of the 3D software, Davé notes, is in direct response to requests from radiologists and healthcare providers. Women with dense breast tissue are four to five times more likely to develop breast cancer and are notoriously far more difficult to diagnose by mammography alone. Informing women of their breast-tissue type and the increasing availability of better diagnostic tools are growing national trends. The Breast Density and Mammography Reporting Act, pending U.S. legislation, would require doctors to inform patients if they have dense breast tissue so that additional screening options can be explored. Currently, 28 states have regulations requiring such notifications.
"Our goal is to discover invasive breast cancer in dense breasts as early as possible in order to prevent the ravages of both the disease and its treatment," said Dr. Kevin M. Kelly, SonoCiné inventor and founder. "And every advancement we make that allows for a more thorough investigation of potential cancers could save more lives, making this 3D multiplanar reconstruction software truly leading-edge."
SonoCiné AWBUS technology and its new 3D whole breast multiplanar reconstruction (MPR) software connect to any ultrasound machine. The software was developed to provide radiologists with an effective, systematic and automated screening examination for the early detection of cancer in dense breast tissue. It requires no injections, radiation or compression, and is pain-free. The SonoCiné technology enables healthcare professionals to quickly detect very small cancers. Tumors as small as 5 mm (1/5") visually "pop" against a bright background and highlight potential areas of concern. Clinical studies, such as this from the Journal of the American Medical Association, show that adding ultrasound, like SonoCiné, to an annual mammogram improves cancer detection results.
Based in Reno, Nev., SonoCiné, Inc., is a privately owned research, development and manufacturing company.